AWM
RARE icon

Activest Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Activest Wealth Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33 Hold
1
– – ﹤0.01% 1306
2026
Q1 		$21 Sell
1
-37
-97% -$833 ﹤0.01% 1208
2025
Q4 		$874 Buy
38
+37
+3,700% +$1.22K ﹤0.01% 958
2025
Q3 		$30 Sell
1
-7
-88% -$210 ﹤0.01% 1108
2025
Q2 		$291 Buy
+8
New +$288 ﹤0.01% 938
2025
Q1 		– Sell
-1
Closed -$42 – 1151
2024
Q4 		$42 Buy
+1
New +$50 ﹤0.01% 767

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Activest Wealth Management's RARE Position: Q2 2026 in Review

Activest Wealth Management held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 1 share worth $33. The position accounts for ﹤0.01% of the portfolio, ranked #1306.

Activest Wealth Management first reported a position in RARE in Q4 2024 and has held it in 6 quarters since. The position peaked at $874 in Q4 2025. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Activest Wealth Management held 1 share of Ultragenyx Pharmaceutical worth $33 as of Q2 2026.
  • Activest Wealth Management left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1306 holding.
  • Activest Wealth Management first reported a position in Ultragenyx Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • Activest Wealth Management's Ultragenyx Pharmaceutical position peaked at $874 in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.